Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies.
暂无分享，去创建一个
K. Bhalla | G. Garcia-Manero | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | C. Dinardo | J. Burger | N. Pemmaraju | N. Jain | N. Short | Y. Alvarado | S. Pierce | W. Fiskus | K. Sasaki | Darla Miller | N. Wilson | W. Qiao | G. Issa | M. Konopleva | J. Senapati | Naval G Daver | J. Khoury | L. Masarova